Hsbc Holdings PLC Karuna Therapeutics, Inc. Transaction History

Hsbc Holdings PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$161.01 - $317.85 $8.46 Million - $16.7 Million	52,557 Added 437.98%	64,557 $20.4 Million
Q3 2023 Nov 13, 2023	BUY	$164.66 - $218.08 $1.98 Million - $2.62 Million	12,000 New	12,000 $2.03 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $737,664 - $1.65 Million	-5,959 Reduced 69.27%	2,644 $603,000
Q2 2022 Aug 11, 2022	SELL	$93.97 - $143.33 $14,283 - $21,786	-152 Reduced 1.74%	8,603 $1.09 Million
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $145,284 - $194,451	1,469 Added 20.16%	8,755 $1.11 Million

Q4 2021 Feb 11, 2022	BUY	$110.64 - $159.4 $806,123 - $1.16 Million	7,286 New	7,286 $954,000
Q4 2019 Feb 14, 2020	SELL	$11.44 - $123.99 $356,561 - $3.86 Million	-31,168 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.05 - $27.35 $500,246 - $852,444	31,168 New	31,168 $509,000

333K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.